Effect of sacubitril valsartan sodium on cardiomyocyte apoptosis by inhibiting Bax/caspase-3 pathway

doi:10.3969/j.issn.1000-1565.2023.06.009

Abstract

Abstract: To explore the mechanism of sacubitril valsartan sodium(LCZ696)on myocardial apoptosis with heart failure, a heart failure model of SD rats was established by intraperitoneal injection of doxorubicin. After successful model building, rats were randomly divided into HF group, valsartan group, and LCZ696 low(LCZ-L)group, LCZ696 high group(LCZ-H),and control group. After 8 weeks of treatment, the change of MAP, weight and HR were observed. The serum contents of BNP, CK-MB,CK, AST and ALT were detected. The improvement of cardiac function in each group was evaluated by ultrasound. Rat left ventricular myocardial tissue was subjected to HE and Tunel staining; the expression of- DOI:10.3969/j.issn.1000-1565.2023.06.009沙库巴曲缬沙坦钠通过Bax/caspase-3信号通路抑制心肌细胞凋亡李亚芹,刘毅,王潇伟,崔红根,康世鑫,徐占稳(河北大学附属医院心血管内科,河北保定 071000)摘要:为了探索沙库巴曲缬沙坦钠(LCZ696)抑制心衰心肌细胞凋亡的作用机制,腹腔注射盐酸阿霉素构建SD大鼠心衰模型,模型构建成功后随机分为心衰组(HF)、缬沙坦组(Val)、LCZ696低剂量组(LCZ-L)、LCZ696高剂量组(LCZ-H),空白组(Control),治疗8周后观察大鼠平均动脉压(MAP)、体质量、心率(HR)变化,检测血清中脑钠肽(BNP)、肌酸激酶同工酶(CK-MB)、肌酸肌酶(CK)、谷草转氨酶(AST)、谷丙转氨酶(ALT)含量,超声评价各组大鼠心功能改善情况;将大鼠左心室心肌组织进行 HE染色和Tunel染色;检测活化的AKT(P-AKT)、Bax、caspase-3蛋白表达.结果显示:心衰大鼠经Val及LCZ696治疗后超声显示心脏功能均有明显改善,BNP、CK-MB、CK、AST、ALT水平下降,其中LCZ-H组降低最明显;HE染色及Tunel染色显示经治疗后细胞凋亡数减少,心肌组织中P-AKT含量较HF增加,Bax、caspase-3蛋白含量较HF组降低,LCZ-H组减少最显著.综上可知,LCZ696通过抑制Bax/caspase-3信号通路抑制心肌细胞凋亡,改善心功能.关键词:沙库巴曲缬沙坦钠;Bax/caspase-3信号通路;心衰;心肌细胞凋亡中图分类号:Q952 文献标志码:A 文章编号:1000-1565(2023)06-0631-07Effect of sacubitril valsartan sodium on cardiomyocyte apoptosis by inhibiting Bax/caspase-3 pathwayLI Yaqin, LIU Yi,WANG Xiaowei, CUI Honggen,KANG Shixin,XU Zhanwen(Department of Cardiovascular Medicine, Affiliated Hospital of Hebei University, Baoding 071002,China)Abstract: To explore the mechanism of sacubitril valsartan sodium(LCZ696)on myocardial apoptosis with heart failure, a heart failure model of SD rats was established by intraperitoneal injection of doxorubicin. After successful model building, rats were randomly divided into HF group, valsartan group, and LCZ696 low(LCZ-L)group, LCZ696 high group(LCZ-H),and control group. After 8 weeks of treatment, the change of MAP, weight and HR were observed. The serum contents of BNP, CK-MB,CK, AST and ALT were detected. The improvement of cardiac function in each group was evaluated by ultrasound. Rat left ventricular myocardial tissue was subjected to HE and Tunel staining; the expression of- 收稿日期:2023-06-19 基金项目:河北省卫健委医学科学研究项目(20200203) 第一作者:李亚芹(1973—),女,河北定州人,河北大学附属医院副教授/副主任医师,主要从事冠心病、心力衰竭疾病研究.E-mail:liyqin2014@163.com 通信作者:刘毅(1988—),男,河北安国人,河北大学附属医院主治医师,主要从事冠心病、心衰诊治及介入治疗研究.E-mail:824516368@qq.com王潇伟(1988—),女,河北保定人,河北大学附属医院主治医师,主要从事冠心病及心衰治疗研究.E-mail:775723357@qq.com第6期李亚芹等:沙库巴曲缬沙坦钠通过Bax/caspase-3信号通路抑制心肌细胞凋亡P-AKT, Bax, and caspase-3 proteins was detected. The results showed that heart function improvement after valsartan and LCZ696 treatment.The BNP, CK-MB, CK, AST, and ALT levels were decreased. The most significant reduction was observed in the LCZ-H group. HE and Tunel staining showed decreased myocardial collagen content and apoptosis number after treatment. P-AKT in myocardial tissue increased compared with HF group, Bax and caspase-3 protein decreased compared with HF group, and LCZ-H decreased most significantly. The study show that LCZ696 inhibited cardiomyocyte apoptosis and improved cardiac function by inhibiting the Bax/caspase-3 signaling pathway.

Key words: sacubitril valsartan sodium, Bax/caspase-3 signaling pathway, heart failure, cardiomyocyte apoptosis

CLC Number:

Q952

LI Yaqin, LIU Yi,WANG Xiaowei, CUI Honggen,KANG Shixin,XU Zhanwen. Effect of sacubitril valsartan sodium on cardiomyocyte apoptosis by inhibiting Bax/caspase-3 pathway[J]. Journal of Hebei University(Natural Science Edition), 2023, 43(6): 631-637.

References

[1] FALCAO-PIRES I, LEITE-MOREIRA A F. Diabetic cardiomyopathy: understanding the molecular and celluar basis to progress in diagnosis and treatment[J]. Heart Faill Rev,2012, 17(3): 325-344. DOI: 10.1007/s10741-011-9257-z.
[2] JIA G H,WHALEY-CONNELL A,SOWERS J R. Diabetic cardiomyopathy: a hyperglycaemia and insulin-resistance-induced heart disease[J]. Diabetologia, 2018, 61(1):21-28. DOI: 10.1007/s00125-017-4390-4.
[3] HUYNH K, KIRIAZIS H, DU X J, et al.Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice[J].Free Radical Biology and Med,2013, 60: 307-317. DOI: 10.1016/j.freeradbiomed.2013.02.021.
[4] 陈明,魏易洪,侯玉鸣,等.心力衰竭动物模型研究进展[J].医学理论与实践, 2021, 34(7): 1103-1105. DOI: 10.1938/j.ssn.1001-7585.2021.07.008.
[5] 徐建虎,张琦,杨子庆,等.阿霉素诱导大鼠慢性心衰模型的制备[J].宁夏医科大学学报,2016,38(3): 348-351, DOI:10.16050/j.cnki.issn1674-6309.2016.03.035.
[6] 马琴.阿霉素诱导大鼠慢性心力衰竭模型的制备[J].生物化工, 2019, 5(4): 100-103.DOI:10.3969/j.issn.2096-0387.2019.04.028.
[7] GOTOH T, ENDO M, OIKE Y. Endoplasmic reticulum stress-related inflammation and cardiovascular diseases[J]. Int J Inflam, 2011: Article ID 259462, 8 pages. DOI: 10.4061/2011/259462.
[8] 程友琴,司晓云,李小鹰,等.硫化氢对大鼠压力负荷性心力衰竭发展过程中氧化应激的影响[J].中华老年心脑血管病杂志, 2010, 12(2): 158-161. DOI: 10.3969/j.issn.1009-0126.2010.02.020.
[9] RIEHLE C, BAUERSACHS J. Key inflammatory mechanisms underlying heart failure[J]. Herz, 2019, 44(2): 96-106. DOI: 10.1007/s00059-019-4785-8.
[10] ARAU 'JO J P, FRIÕES F, AZEVEDO A, et al. Variability of high-sensitivity C-reactive protein in chronic heart failure[J]. Cardiology, 2009, 113(3): 180-183. DOI: 10.1159/000189799.
[11] VAN DER HEIDEN K, CUHLMANN S, LUONG L, et al. Role of nuclear factor κB in cardiovascular health and disease[J]. Clin Sci, 2010, 118(10): 593-605. DOI: 10.1042/cs20090557.
[12] YNDESTAD A, DAMÅS J K, ØIE E, et al. Role of inflammation in the progression of heart failure[J]. Curr Cardiol Rep, 2007, 9(3): 236-241. DOI: 10.1007/BF02938356.
[13] OKADA K I, MINAMINO T, TSUKAMOTO Y, et al. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis[J]. Circulation, 2004, 110(6): 705-712. DOI: 10.1161/01.CIR.0000137836.95625.D4.
[14] 张志敏,赵连友,卢凡,等.高同型半胱氨酸对高血压大鼠心肌细胞GRP78和CHOP表达及左室肥厚的影响[J].中国循证心血管医学杂志, 2014, 6(2): 223-226, 228. DOI: 10.3969/j.1674-4055.2014.02.32.
[15] SIMONYAN L, RENAULT T T, DA COSTA NOVAIS M J, et al. Regulation of Bax/mitochondria interaction by AKT[J]. FEBS Lett, 2016, 590(1): 13-21. DOI: 10.1002/1873-3468.12030.
[16] ANTOINE H,CHANNINE,ROGER J. Hajjar,AKT signlling in the failing heart[J]. European Journal of Heart Failure, 2014, 13(8):325-332.DOI:10.1093/eurjhf/hfr080.
[17] SHIOJIMA I, YEFREMASHVILI M, LUO Z Y, et al. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status[J]. J Biol Chem, 2002, 277(40): 37670-37677. DOI: 10.1074/jbc.M204572200.
[18] MANNING B D, TOKER A. AKT/PKB signaling: navigating the network[J]. Cell, 2017, 169(3): 381-405. DOI: 10.1016/j.cell.2017.04.001.
[19] FRUMAN D A, CHIU H, HOPKINS B D, et al. The P53 pathway in human disease[J]. Cell, 2017, 170(4): 605-635. DOI: 10.1016/j.cell.2017.07.029. (